, Tracking Stock Market Picks
Enter Symbol:
Rating: PKI
Hold $51

Perkinelmer, Inc. (NYSE: PKI) reiterated to Hold with price target $51 by Deutsche Bank

Thursday,  Jan 7, 2016  1:25 PM ET by Kristen Bailey

Deutsche Bank reiterated Perkinelmer, Inc. (NYSE: PKI) to Hold with price
target $51. Deutsche Bank rated Perkinelmer, Inc. (NYSE: PKI) to Hold with price target $21 on 10/05/2011, when the price was $19.01.

Perkinelmer, Inc. is a provider of technology, services and solutions to the diagnostics, academic research, environmental monitoring and safety and security markets. During the fiscal year ended December 28, 2008 (fiscal 2008), the Company operated in two segments: Life and Analytical Sciences, and Optoelectronics. Subsequent to the fiscal 2008, the Company operates in two segments: Human Health and Environmental Health. In January 2009, it acquired Opto Technology Inc. (Opto Technology). In December 2008, the Company acquired Arnel, Inc. (Arnel). In December 2008, it shut down the Cellular Screening Fluorescence and Luminescence workstations business, Analytical Proteomics Instruments business, and Proteomics and Genomics Instruments business. In May 2009, the Company acquired Analytica of Branford, Inc. In September 2009, the Company acquired the genetic screening business of Surendra Genetic Labs, Pvt Ltd. and SYM-BIO Lifescience.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy